US cannabis companies struggle to overcome marketing challenges
Firms are building national brands but the federal government prohibits them from advertising to mainstream consumers
New York — US cannabis companies are racing to build national brands and market their wares to mainstream consumers. There is just one problem: it is hard to advertise your product when the federal government considers you a drug dealer. Facebook, which like Google prohibits marijuana ads, has kicked some weed sellers off Instagram. Earlier in January CBS declined to air a commercial touting the benefits of medical marijuana during the Super Bowl. Much the way banks are unwilling to finance cannabis startups, television networks and online advertising marketplaces are understandably cautious because the Feds still classify marijuana as a schedule 1 drug alongside heroin and ecstasy. With a growing number of states legalising cannabis for recreational and medical purposes, the US market could surge eight-fold to $80bn in sales by 2030, according to Cowen & Company. But it is hard to see that happening unless companies can market their wares the way beer and liquor companies do. After...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.